X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/immunogenesis-doses-first-patient-in-phase-1a1b-clinical-trial-of-imgs-001-in-relapsed-or-refractory-advanced-solid-tumors-301941636.html
https://www.prnewswire.com/news-releases/immunogenesis-and-cancer-focus-fund-announce-4-5-million-investment-to-support-first-in-human-trial-of-imgs-001-for-relapsed-or-refractory-advanced-solid-tumors-301863976.html
https://www.prnewswire.com/news-releases/immunogenesis-to-present-pre-clinical-data-from-lead-program-at-society-for-immunotherapy-of-cancer-conference-301666763.html
https://www.contractpharma.com/contents/view_breaking-news/2022-05-31/agenus-enters-3-new-clinical-collaborations/?widget=listSection
https://www.biospace.com/article/releases/immunogenesis-appoints-oncology-research-veteran-to-lead-immuno-oncology-clinical-development-targeting-immune-excluded-and-quot-cold-and-quot-cancers/?s=82
https://www.prnewswire.com/news-releases/data-from-immunogenesis-lead-programs-presented-in-six-posters-at-society-for-immunotherapy-of-cancer-sitc-conference-301422972.html
https://www.prnewswire.com/news-releases/data-from-immunogenesis-lead-programs-to-be-presented-at-society-for-immunotherapy-of-cancer-sitc-conference-301414997.html
https://www.contractpharma.com/contents/view_breaking-news/2021-07-28/immunogenesis-opens-research-lab-adds-key-roles/?widget=listSection
Market Place
Share 
